FAS and FAS ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis

Arthritis and Rheumatism

Volumn 42, Issue 2, 1999, Pages 291-298

  Sugiura, Tomoko ^a   Murakawa, Yohko ^a   Nagai, Atsushi ^a   Kondo, Masahiro ^a   Kobayashi, Shotai ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; PREDNISOLONE;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; MALE; MOLECULAR INTERACTION; MUSCLE BIOPSY; MUSCLE INJURY; MYOPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DERMATOMYOSITIS; DNA; FAS LIGAND PROTEIN; FEMALE; HUMANS; IN SITU NICK-END LABELING; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MUSCLE FIBERS; MUSCLE, SKELETAL; POLYMYOSITIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033005249     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199902)42:2<291::AID-ANR11>3.0.CO;2-1     Document Type: Article

References (31)

1. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV. Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988;23:168-73.
2. Hohlfeld R, Goebels N, Engel AG. Cellular mechanisms in inflammatory myopathies. Baillieres Clin Neurol 1993;2:617-35.
3. Yamada H, Nakagawa M, Higuchi I, Ohkubo R, Osame M. Type II muscle fibers are stained by anti-Fas antibody. J Neurol Sci 1995;134:115-8.
4. Inukai A, Kobayashi Y, Honda H, Sohue G. Fas antigen is expressed in human diseased muscles, but does not link to apoptosis. Nippon Rinsho 1996;54:1992-6.
5. Schneider C, Gold R, Dalakas MC, Schmied M, Lassmann H, Toyka KV, et al. MHC class-I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis. J Neuropathol Exp Neurol 1996;55:1205-9.
6. Behrens L, Bender A, Johnson MA, Hohlfeld R. Cytotoxic mechanisms in inflammatory myopathies; co-expression of Fas and protective bcl-2 in muscle fibers and inflammatory cells. Brain 1997;120:929-38.
7. Bohan A, Peter JB, Bowman RL, Pearson CM. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-86.
8. Gold R, Schmied M, Giegerich G, Breitchopf H, Hartung HP, Toyka KU, et al. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994;71:219-25.
9. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169: 1747-56.
10. Trauth BC, Klas C, Peters AMJ, Matzuku S, Moller P, Flak W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-5.
11. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
12. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effects of the anti-Fas antibody in mice. Nature 1993;364:806-9.
13. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
14. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
15. Firestein GS, Yeo M, Zvaifler NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995;96:1631-8.
16. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996;70:199-206.
17. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yoehara M, Yonehara S. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc Natl Acad Sci U S A 1990;87:9620-4.
18. Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, et al. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 1994;93:1029-34.
19. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, et al. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 1995;99:245-50.
20. Waldner H, Sobel RA, Howard E, Kuchroo VK, Fas and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997;159:3100-3.
21. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jerkins NA, Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356: 314-7.
22. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
23. Rieux-Laucat F, Deist FL, Hivroz C, Roberts LAG, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268: 1347-9.
24. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
25. Nagata S, Goistein P. The Fas death factor. Science 1995;267: 1449-56.
26. Tews DS, Goebel HH. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol 1997;56:150-6.
27. Yagita H, Hanabuchi S, Asano Y, Tamura T, Nariuchi H, Okumura K. Fas-mediated cytotoxicity - a new immunoregulatory and pathogenic function of Th1 CD4+ T cells. Immunol Rev 1995; 146:223-39.
28. Hohlfeld R, Engel AG. The immunology of muscle. Immunol Today 1994;15:269-74.
29. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. V. Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 1988;23: 493-9.
30. Orimo S, Koga R, Nakamura N, Arai M, Tamaki M, Sugita H, et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994;4:219-26.
31. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996;97:2905-10.